JPRN-C000000210已完成2 期
Clinical trial of postoperative adjuvant chemotherapy with carboplatin/paclitaxel according to the results of collagen gel droplet embedded culture drug sensitivity test (CD-DST) in completely resected non-small-cell lung cancer - Postoperative adjuvant chemotherapy according to the results of drug sensitivity test in non-small-cell lung cancer
Department of General Thoracic Surgery, Osaka University Graduate School of Medicine0 个研究点目标入组 92 人开始时间: 2005年9月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 92
研究概览
简要总结
The chemosensitivity to carboplatin and/or paclitaxel was 76%. The 5-year OS rates were 71, 73, and 75% for all, CD-DST success, and chemosensitive patients, respectively. The 5-year DFS and OS rates of the chemosensitive patients who completed adjuvant chemotherapy using carboplatin/paclitaxel were 68 and 82%, respectively. The 5-year DFS and OS rates of the patients with stage II-IIIA chemosensitive NSCLC were 58 and 75%, respectively.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1, Heart diseases required treatment. 2, Myocardial infarction within 6 months. 3, Liver cirrhosis. 4, Symptomatic interstitial pneumonia or pulmonary fibrosis proven in the chest X-ray. 5, Active bowel hemorrhage required repeated transfusion. 6, Uncontrollable diabetes mellitus. 7, Ileus or subileus. 8, Active infection. 9, Peripheral neuropathy. 10, Psychological disorder required medication. 11, Drug allergy against cremophor EL(polyoxethylated castor oil). 12, During pregnancy or lactation. 13, Inadequate condition diagnosed by the primary physician.
研究者
相似试验
已完成
1 期
The Feasibility Study of Adjuvant Chemotherapy with TS-1+Carboplatin followed by TS-1 maintenace in Patients with Completely Resected Stage II-IIIA Non-Small-Cell Lung Canceron-small-cell lung cancerJPRN-UMIN000005041Setouchi Lung Cancer Group89
已完成
3 期
Study of Adjuvant ONO-4538 With Resected Gastric CancerGastric CancerNCT03006705Ono Pharmaceutical Co. Ltd800
已完成
不适用
Randomized contorol trial of transarterial chemoinfusion with cisplatin-lipiodol susupension or miriplatin-lipiodol suspension for advanced HCCHepatocellular carcinomaJPRN-UMIN000003452First Department of Internal Medicine,Gifu University Hospital98
已完成
2 期
Phase II trial of dosetaxel and carboplatin as neoadjuvant chemotherapy in patients with stage Ib2-II nonsquamous cell carcinoma of uterine cervixnonsquamous cell carcinoma of uterine cervixJPRN-UMIN000000560Sankai Gynecology Study Group (SGSG)61
已完成
2 期
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesNon-Small Cell Lung CancerNCT00490659Eli Lilly and Company13
